Gladius Capital Management LP Intercept Pharmaceuticals, Inc. Transaction History

Gladius Capital Management LP

  • $166 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Dec 18, 2023
BUY
$12.53 - $21.71 $23,794 - $41,227
1,899 New
1,899 $25,000
Q1 2023

May 09, 2023
SELL
$12.53 - $21.71 $8,344 - $14,458
-666 Reduced 25.96%
1,899 $26,000
Q4 2022

Dec 18, 2023
BUY
$11.61 - $16.11 $29,779 - $41,322
2,565 New
2,565 $31,000
Q4 2022

Feb 02, 2023
BUY
$11.61 - $16.11 $29,779 - $41,322
2,565 New
2,565 $32,000

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Gladius Capital Management LP Portfolio

Follow Gladius Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email